<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-LAO-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Lao (la R&#xE9;publique d&#xE9;mocratique populaire): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Lao People&apos;s Democratic Republic (the): Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Lao People&apos;s Democratic Republic (the)</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="LA" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="LA" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Vientiane</narrative>
   </name>
   <administrative code="LA" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>17.96667 102.6</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1900574</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2111692</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1378262</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">36598.22</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">36598.22</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="LAOPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">56000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-GFA2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">337292</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-IBRD2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-SABIN2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">33741</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-SABIN</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">48177</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">611280</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">614084</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-CDC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">60000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">22400</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">323643</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-GFA2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">40415</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">691803</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">773432</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">199386</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-IBRD2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">100000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">42010</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">542970</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="LAOPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">493896</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001736">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">60000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000956">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">56000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">22400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003175">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-30"></transaction-date>
   <value currency="USD" value-date="2020-11-30">153964</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005239">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-14"></transaction-date>
   <value currency="USD" value-date="2021-10-14">17399</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005238">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-14"></transaction-date>
   <value currency="USD" value-date="2021-10-14">43570</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005636">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-15"></transaction-date>
   <value currency="USD" value-date="2021-11-15">76982</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005636">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-15"></transaction-date>
   <value currency="USD" value-date="2021-11-15">76982</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007013">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-08"></transaction-date>
   <value currency="USD" value-date="2021-12-08">76982</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-24563</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">24563</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001066">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-8408</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001233">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">10169</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003851">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">69557</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">207539</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">58435</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-207539</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-58435</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000519">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-25"></transaction-date>
   <value currency="USD" value-date="2020-02-25">87848</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000817">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-12"></transaction-date>
   <value currency="USD" value-date="2020-03-12">57435</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003361">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-16"></transaction-date>
   <value currency="USD" value-date="2020-08-16">49490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001198">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">68256</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GFA (GFA Consulting Group GmbH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GFA Consulting Group GmbH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001134">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002781">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-17"></transaction-date>
   <value currency="USD" value-date="2021-06-17">100000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001042">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">32800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SABIN</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001209">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">940</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SABIN</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">42624</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-2873</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">19415</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-10</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">10</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">3521</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-7</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">7</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">15660</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">15095</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-7</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">7</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000957">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">611280</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">620136</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">71667</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">542970</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000958">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">614084</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">595862</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">177570</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">493896</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-lao-pdr-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Lao PDR 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-lao-pdr-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Lao PDR 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-lao-pdr-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Lao PDR 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-lao-pdr-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Lao PDR 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-lao-pdr-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Lao PDR 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-lao-pdr-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Lao PDR 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-lao-pdr-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Lao PDR 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-lao-pdr-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Lao PDR 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-LAO" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Updated analysis of the impact of COVID-19 on routine immunization and health financing and sectoral budget for 2021/2022 conducted;
2. Analysis on the costs of immunization service delivery to inform options for scaling up essential health services including immunization conducted.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to MoH to strengthen capacity on planning for immunisation financing, monitor the impact of COVID-19 on health financing, use evidence for planning and policy making and support learning/advocacy activities involving MoH and MoF for sustainable financing for immunization by focusing on domestic resource mobilization, improving efficiency.
1. TA to support to NIP on strategic costing and health financing for routine immunisation.
2. Assessment of the impact of COVID-19 on health financing including sustainable immunization financing and budget analysis for 2020/2021.
3. Engagement of MoF/MoH officials on domestic resource mobilization and transition readiness discussions through joint learning network and other learning events.
4. Analysis to inform options for scaling up essential health services and assess policy options for mobilizing domestic sources to delivery EHSP including immunization services (fiscal space analysis) to inform sustainability and transition planning.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">(1) Analysis has been regularly updated and the latest update is based on the macro-economic data in the East Asia and Pacific Economic Update, released in October 2021. The update is integrated with NHA data, DHIS2 data for immunization coverage, the revised budget plan for 2021.
(2) Given the pressing needs of planning and costing of COVID-19 vaccination, the team has engaged in costing analysis for COVID-19 vaccination, working closely with other development partners such WHO. The preliminary result has been disseminated in September 2021. Furthermore, the WB team has been involved in formulating microplanning for the vaccination, including detailed budgeting and costing analysis for outreach.
(3) Engaged representatives from DOF and NHIB in global and regional learning exchanges on domestic resource mobilization and health financing for UHC, including the Joint Learning Network (JLN) and the 5th Meeting of the Montreux Collaborative. Those collaborative meetings help generating and exchanging ideas and lessons for Lao participants and others to facilitate the implementation of the Health Financing Strategy 2021-2025 and Vision 2030 for Lao PDR.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Assessment of the impact of COVID-19 on health financing including sustainable immunization financing and budget analysis for 2020/2021;
2. Engagement of MoF/MoH officials on domestic resource mobilization and transition readiness discussions through joint learning network and other learning events.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to MoH to strengthen capacity on planning for immunisation financing, monitor the impact of COVID-19 on health financing, use evidence for planning and policy making and support learning/advocacy activities involving MoH and MoF for sustainable financing for immunization by focusing on domestic resource mobilization, improving efficiency.
1. TA to support to NIP on strategic costing and health financing for routine immunisation.
2. Assessment of the impact of COVID-19 on health financing including sustainable immunization financing and budget analysis for 2020/2021.
3. Engagement of MoF/MoH officials on domestic resource mobilization and transition readiness discussions through joint learning network and other learning events.
4. Analysis to inform options for scaling up essential health services and assess policy options for mobilizing domestic sources to delivery EHSP including immunization services (fiscal space analysis) to inform sustainability and transition planning.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">(1) Analysis on the early impact of COVID-19 on health financing in Lao PDR was conducted and the report titled ?Building a resilient health system for health emergency: Addressing system constraints for improving financing and service delivery? was published in the Lao Economic Monitor in 2020. The analysis has been regularly updated when the new macro-economic data is released. The next update is planned in September. 
(2) Engaged representatives from MOF (Budget Department and External Finance and Debt Management Department) and MOH (Department of Finance &amp; National Health Insurance Bureau) in the discussion on Bi-regional Workshop on Health Financing for Universal Health Coverage in Asia &amp; the Pacific beyond COVID-19, focusing on Increasing Domestic Resource Mobilization in February 2021. Engaged DOF representative in the Joint Learning Network COVID-19 Vaccine Financing Event where outputs of COVID-19 vaccine costing case of Lao PDR was presented; Engaged senior officials of DOF &amp; NHIB in the JLN event on the Macro-Fiscal Impact of COVID-19 : A Domestic Resource Mobilization Perspective and the JLN learning course on Budget Execution Learning Exchange.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Continue advocacy for transition and sustainability 2. Support implementation of health financing strategy for domestic resource mobilization and sustainable financing for UHC.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for mobilizing domestic resources for the health sector including the national immunization program.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Completed the EHSP costing analysis. The report is submitted for endorsement by the Minister of Health. Continued analysis on policy options for financing ESP scale up and options for mobilizing domestic sources is planned under 2021 TCA.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for mobilizing domestic resources for the health sector including the national immunization program.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Completed the EHSP costing analysis. The report is submitted for endorsement by the Minister of Health. Continued analysis on policy options for financing ESP scale up and options for mobilizing domestic sources is planned under 2021 TCA.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Feasibility and timing of IPV intro and OPV withdrawal is reviewed by NITAG and its meeting minute is available; (2) MR PoA coordination meeting is held and its minute is availble</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="NVI (link to HR2-6, HR2-7)- support NITAG and MOH decision making on use of IPV2 and OPV withdrawal; continue implementation of national strategy and plan of action for MR elimination">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">(1) MINOR DELAYS - NITAG has been focused on COVID vaccine guidance; Feasibility and timing of IPV intro and OPV withdrawal will be discussed by NITAG in Q1 2022; (2) ON TRACK MR PoA coordination meeting was held on 8 Nov and minutes are available</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) MR PoA coordination meeting is held and its minute is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="NVI (link to HR2-6, HR2-7)- support NITAG and MOH decision making on use of IPV2 and OPV withdrawal; continue implementation of national strategy and plan of action for MR elimination">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">The MR PoA coordination meeting was held (31 March 2021) and its minute is attached</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Post-introduction evaluation completed for HPV dose 1 and 2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support/NVI (cont&apos;d) to (1) conduct rapid convenience monitoring (RCM) on HPV introduction and post-introduction evaluation protocol development, (2) switch MR presentations (timing tbc), and (3) prepare for introduction of rotavirus vaccine in 2020; (4) Technical assistance in the planning, implementation, and evaluation of MR SIA">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Three teams completed the Lao PDR HPV Post-Vaccine Introduction Evaluation in March and April 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support/NVI (cont&apos;d) to (1) conduct rapid convenience monitoring (RCM) on HPV introduction and post-introduction evaluation protocol development, (2) switch MR presentations (timing tbc), and (3) prepare for introduction of rotavirus vaccine in 2020; (4) Technical assistance in the planning, implementation, and evaluation of MR SIA">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Three teams completed the Lao PDR HPV Post-Vaccine Introduction Evaluation in March and April 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Mid-year workplan progress report is available; (2) At least 2 ICC meetings have been convened and minutes are available; (3) Drafting of Gavi Board paper on Lao PDR tailored transition including development of scenarios and analysis of trade-offs; (4) formal scoping of Training centre for ongoing EPI/RMNCAH capacity building completed and agreement on way forward (link to HSS HR-30)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support and capacity building (link to HR2-11, HR2-14, HR2-15, HR2-16): (1) LMC, governance, programme management including support towards the efficient implementation of annual MCHC workplan (including Gavi HSS workplan) implementation; (2) development of eLearning and roll-out of tools to develop capacity during pre-service and in-service, especially at lowest levels; (3) strategic and operational planning including the translation of the cMYP to an annual operational plan (AOP) that is aligned to other relevant health sector plans">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">- June ICC meeting held and Q4 ICC being scheduled. 
 - Drafting of Gavi Board paper on Lao PDR tailored transition including development of scenarios and analysis of trade-offs - has been delayed related to Gavi governance calendar
- formal scoping of Training centre for ongoing EPI/RMNCAH capacity building completed and agreement on way forward (link to HSS HR-30)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Annual MCHC workplan is developed with prioritized activities, clear technical leads, DP and financial support; (2) eLearning strategy developed including training materials finalized and to high level of quality and completeness; 2 eLearning tools (TBC AEFI and vaccine hesitancy) are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support and capacity building (link to HR2-11, HR2-14, HR2-15, HR2-16): (1) LMC, governance, programme management including support towards the efficient implementation of annual MCHC workplan (including Gavi HSS workplan) implementation; (2) development of eLearning and roll-out of tools to develop capacity during pre-service and in-service, especially at lowest levels; (3) strategic and operational planning including the translation of the cMYP to an annual operational plan (AOP) that is aligned to other relevant health sector plans">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Annual Operational Plan is available and being updated for 2021; training plan and development of materials for University of Health Sciences (UHS) curriculum is underway.
WHO CO continues to update the EPI webpage with the most current training materials -- so far in 2021, the focus in on COVID vx training materials
https://sites.google.com/view/epilao</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support and capacity building (link to HR2-11, HR2-14, HR2-15, HR2-16): (1) LMC, governance, programme management including support towards the efficient implementation of annual MCHC workplan (including Gavi HSS workplan) implementation; (2) development of eLearning and roll-out of tools to develop capacity during pre-service and in-service, especially at lowest levels; (3) strategic and operational planning including the translation of the cMYP to an annual operational plan (AOP) that is aligned to other relevant health sector plans">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">these appear to be June TCA milestones</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Cold Chain Inventory System is updated for 2021 after implementation of CCEO;
2. SMS based Temperature monitoring system developed and ready for installation;
3. Cold Chain Hubs staff received training on repair of cold chain equipment.
4. Cold Chain Hubs fully equipped with Cold Chain Tools.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide oversight for HSS and technical capacity of national and sub-national team in cold chain system and technical assistance to implement GAVI HSS 3 and Top up #2 activities:
1. Coordinate the training of pool of cold chain technicians to execute the country led service bundled project;
2. Follow up evaluation the quality of training for technicians on preventive maintenance, installation, trouble shooting and repair of the new cold chain equipment (CCE); the designated health worker on correct use and preventive maintenance of the new CCE.
3. Plan and Evaluate and participate on random quality survey at the end of the installation (using UNICEF SD methodology).
4. Support MOH to update and maintain the government?s CCEI (cold chain equipment inventory) on an on-going basis and as referenced deliverable for the CCEOP process.
5. Provide technical support to establish and install SMS based Temperature Monitoring System.
6. Mentor, supervise and provide regular training to Center of Excellence for staff at National Store and 6 regional Cold Chain hubs on Cold chain management, preventive and basic maintenance.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. Cold Chain Inventory System system is being updated since the CCE still being delivered. Accurate and up-to-date cold chain equipment inventories (CCEIs) has been developed which is online based, and all CCE which are installed currently being recorded within a health system. Updated CCEI data enable governments to make informed decisions on vaccine distribution and storage, equipment maintenance and repair, routine and campaign immunization planning and procurement.
The challenge is maintenance of an updated CCE Inventory which is resource and labor-intensive.
Next year NIP will work on adoption a CCEI
Information System that was designed and tailored for operation in Lao P.D.R. 
2. SMS based Temperature monitoring system developed devices arrived in November and 1 RTMD has been installed, the remaining 5 will be installed in December in all Cold Chain Hubs; 
3. In close cooperation with private sector partners, UNICEF developed a training video material on installing cold chain equipment. Online training of cold chain focal points has been completed, and 18 staff have been trained to provide training materials, forms, and reporting templates on the installation of fridges and freezers. 
 4. All six Cold Chain Hubs and all provinces now fully equipped with Cold Chain Tools.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Five Cold Rooms are installed and operational;
2.Supplied 157 Cold chain equipment are installed and evaluated;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to Gavi HSS3 objective 4,HTU-4; HR 54, HR-55,HR- 58, HTU-2; Facilitate Validation and execution of Operational Deployment Plan, conducting country specific stakeholder mapping, timely readiness of sites for installation, quality of data and mapping of country specific risk and agree on its management strategy.
1. Provide technical assistance and guidance on technical aspects of CCEs and SDDs, ensuring that the sites are ready and appropriate for the deployment and installation of the equipment.
2. Monitor implementation of preventive maintenance plan as per country application, and monitor deployment and installation of CCEs, in coordination with the Provincial program management teams
3. Prepare a report on the correct deployment of equipment and implementation of the CCEOP project in general.
4. Plan, coordinate and ensure quality of trainings conducted for installation of ILRs and SDDs. Ensure that there is relevant and maximum participation from the cold chain technicians.
5.Assess the technical procedures during installation and report on the process and quality of the installation of the cold chain equipment">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. Five cold rooms have been installed and fully functional. It is also report in other milestone. Herewith the private company executive summary report attached and technical description briefly provided. 
2. Total of 157 cold chain equipment arrived and currently being distributed by locally recruited logistic company. The list of health facilities and geographical locations are attached.
3. The next shipment of 183 cold chain equipment is planned for July 9, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Next batch of 720 Cold chain equipment are deployed;
2. Cold chain technicians are trained in basic and preventive maintenance;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to Gavi HSS3 objective 4,HTU-4; HR 54, HR-55,HR- 58, HTU-2; Facilitate Validation and execution of Operational Deployment Plan, conducting country specific stakeholder mapping, timely readiness of sites for installation, quality of data and mapping of country specific risk and agree on its management strategy.
1. Provide technical assistance and guidance on technical aspects of CCEs and SDDs, ensuring that the sites are ready and appropriate for the deployment and installation of the equipment.
2. Monitor implementation of preventive maintenance plan as per country application, and monitor deployment and installation of CCEs, in coordination with the Provincial program management teams
3. Prepare a report on the correct deployment of equipment and implementation of the CCEOP project in general.
4. Plan, coordinate and ensure quality of trainings conducted for installation of ILRs and SDDs. Ensure that there is relevant and maximum participation from the cold chain technicians.
5.Assess the technical procedures during installation and report on the process and quality of the installation of the cold chain equipment">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. Out of 967 CCE, 340 has been distributed and 100 was installed. Currently internal inspection is ongoing. The remaining batch of CCE is expected in March 2022. 
2. UNICEF provided technical assistance to the MoH to prepare the submission of the application to COVAX to expand the cold chain capacity of the National Store. The technical project proposal included preparation of expansion design, refurbishment of the national store, procurement, and installation of two (2) Walk-in Cold Rooms. Independent Review Committee has endorsed the technical proposal, and the project implementation process is underway. ?	A technical proposal to refurbish and renovate the National Vaccine Store has been submitted to MoH. The bidding process is ongoing, and the renovation is planned to start in February 2022. The procurement of two large volume (40m3) Walk-in Cold Rooms is in the process and expected to arrive in April 2022. ?	Due to lockdown, and travel restriction measures imposed by the government, training of cold chain focal points on the installation of cold chain equipment has been postponed; The planned training was designed to be skilled based. The video-training material has been developed, and online training conducted to overcome the travel restriction barrier.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Pool of cold chain technicians are trained on country led service bundled implementation and their capacity is evaluated;
2. Regular PMT is conducted in every province to ensure the Country Led Service Bundled implementation is per agreed timeframe.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide oversight for HSS and technical capacity of national and sub-national team in cold chain system and technical assistance to implement GAVI HSS 3 and Top up #2 activities:
1. Coordinate the training of pool of cold chain technicians to execute the country led service bundled project;
2. Follow up evaluation the quality of training for technicians on preventive maintenance, installation, trouble shooting and repair of the new cold chain equipment (CCE); the designated health worker on correct use and preventive maintenance of the new CCE.
3. Plan and Evaluate and participate on random quality survey at the end of the installation (using UNICEF SD methodology).
4. Support MOH to update and maintain the government?s CCEI (cold chain equipment inventory) on an on-going basis and as referenced deliverable for the CCEOP process.
5. Provide technical support to establish and install SMS based Temperature Monitoring System.
6. Mentor, supervise and provide regular training to Center of Excellence for staff at National Store and 6 regional Cold Chain hubs on Cold chain management, preventive and basic maintenance.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Total of 12 Cold Chain technicians from each provinces are trained (on the job training due to COVID19 lockdown measures) on installation of cold chain equipment. Two regular PMT is conducted at national level to ensure the Country Led Service Bundled implementation is per agreed timeframe. Provincial PMT is planned in July.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Continue providing TA to health facilities for QPS implementation 2. Monitor the performance and quality through QPS implementation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to HANSA design and implementation, specially on the new quality and performance scorecard (QPS) for health services including immunization">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. The SOP for implementing QPS is included in the QPS manual and the QPS tools are at its near-ready status for use with finalization expected in mid-July 2021. 
2. The QPS trainings of district assessors are expected to commence in August 2021 subject to the COVID-19 lockdown situation. Field test on QPS tool was carried out by Department of Healthcare and Rehabilitation (DHR) during in 17-21 February 2020. The roll out is pending due to COVID-19 lockdown. 
Continued TA to HANSA implementation readiness. All expected to be completed by mid July.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to HANSA design and implementation, specially on the new quality and performance scorecard (QPS) for health services including immunization">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. The SOP for implementing QPS is included in the QPS manual and the QPS tools are at its near-ready status for use with finalization expected in mid-July 2021. 
2. The QPS trainings of district assessors are expected to commence in August 2021 subject to the COVID-19 lockdown situation. Field test on QPS tool was carried out by Department of Healthcare and Rehabilitation (DHR) during in 17-21 February 2020. The roll out is pending due to COVID-19 lockdown. 
Continued TA to HANSA implementation readiness. All expected to be completed by mid July.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regular and timely reporting of DLI immunization indicators through the program management dashboards</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building of national and subnational level staff for regular monitoring and reporting of MCH indicators">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Provided TA for developing dashboard for the 50 low performing districts for immunization coverage and integrated outreach as part of DLI monitoring under HGNDP/HANSA.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building of national and subnational level staff for regular monitoring and reporting of MCH indicators">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Provided TA for developing dashboard for the 50 low performing districts for immunization coverage and integrated outreach as part of DLI monitoring under HGNDP/HANSA.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. The guideline on participatory village planning is developed and incorporated into and microplanning guideline as well as the NSEDP village plans; 2; Training modules for HC staff in inter-personal and communication, evidence based planning and monitoring to faciliate use of immunization services at fixed sites is developed; 3. Village drug kit and essential commodities for VHV are identified and customized to village need;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to integrate Immunization and RMNCAH service delivery and implementation;Improve community capacity for evidence-based planning, budgeting, supervision and monitoring integrated immunization interventions following the District-Community Health Strengthening approach, as part of the implementation of the Gavi assisted Health System Strengthening programme: 
1) At community level, create demand for and ensure the provision of essential quality integrated services; influence social norms or barriers that deny the rights of children and women to access care, and related behaviors; 
2) Improve accountability of local health and community leaders in the key determinants of health and for health outcomes; 3) Provide overall guidance and TA support to MOH partners on the Gavi-assisted HSS programme monitoring">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. The village planning components are incorporated into microplanning guidelines and the microplanning expanded to wider integrated RMNCH; ToT training completed; 
2. As part of the implementation of the Primary Health Care policy and service delivery at the community level, MoH developed a set of messages and visuals on RMNCAH and nutrition, WASH, CP, ECD, that will be used for the 14 Village Health Volunteer home contacts during the 1000 day period. Under the leadership of UNICEF, MOH (including MCHC/ NIP/ NC/ CCEH), UNJP, NGOs and other partners actively participated in the development process. 
3. Training modules for HC staff in inter-personal and communication have been developed and attached in this report; IPC training conducted in 7 provinces and 14 high-risk districts;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to integrate Immunization and RMNCAH service delivery and implementation;Improve community capacity for evidence-based planning, budgeting, supervision and monitoring integrated immunization interventions following the District-Community Health Strengthening approach, as part of the implementation of the Gavi assisted Health System Strengthening programme: 
1) At community level, create demand for and ensure the provision of essential quality integrated services; influence social norms or barriers that deny the rights of children and women to access care, and related behaviors; 
2) Improve accountability of local health and community leaders in the key determinants of health and for health outcomes; 3) Provide overall guidance and TA support to MOH partners on the Gavi-assisted HSS programme monitoring">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. The village planning components are incorporated into microplanning guidelines and the microplanning expanded to wider integrated RMNCH; ToT training completed; 
2. As part of the implementation of the Primary Health Care policy and service delivery at the community level, MoH developed a set of messages and visuals on RMNCAH and nutrition, WASH, CP, ECD, that will be used for the 14 Village Health Volunteer home contacts during the 1000 day period. Under the leadership of UNICEF, MOH (including MCHC/ NIP/ NC/ CCEH), UNJP, NGOs and other partners actively participated in the development process. 
3. Training modules for HC staff in inter-personal and communication have been developed and attached in this report; IPC training conducted in 7 provinces and 14 high-risk districts;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1)&#xA0;Training(s)&#xA0;will be organized&#xA0;for NIP staff&#xA0;to strengthen capacity to report on immunization expenditures according to the NHA format through JRF/NHA (SHA) conducted; (2) workshop to finalize the NHA report&#xA0;for 2019 and discuss implications/use of the data for policy decisions; (3) Drafting of Gavi Board paper on Lao PDR tailored transition including development of financial scenarios.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Immunization financing - Supporting decision making and implementation of HFS in the context of the 9th NSEDP/HSDP; identification of program enhancements and efficiency gains (ie PCV and/or Penta switch to lower-cost/more sustainable vaccine) to ensure smooth transitoin from Gavi">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Beyond a health crisis, the COVID-19 pandemic has exposed the interconnectedness of health and economies and the importance of sufficient investment in health in Lao PDR. GDP growth is projected to be at -0.4% in 2020 and at 4.6% in 2021;
general government debt as a share of GDP has been significantly increased with 68.3% in 2021 and 69.1% in 2023. COVID-19 impact on the health sector:
 Govt budget cuts by 30% in 2020, which will be continued by 2022; -Donor funding for health: $101M in 2019; COVID-19 response plan costing: $181M in 2020; COVID-19 vaccine procurement and deployment cost for 50% of population coverage by 2021: $61.3M ($51.3M for vaccine procurement; $10M for vaccine deployment)
Key Progress towards successful donor transition: 
In 2016, DHIS2 became the reporting tool and system for eight programs to institutionalize integration of multiple subsystems. 
I. Training(s) will be organized for NIP staff to strengthen capacity to report on immunization expenditures according to the NHA format through JRF/NHA (SHA) conducted; =&gt; NHA training workshops were conducted in Xayabouly province in July and in Xiangkhouang and Huaphan provinces in August. During the workshops, how to report in which format for health expenditure in the health sector including immunization expenditure were covered. II. workshop to finalize the NHA report for 2019 and discuss implications/use of the data for policy decisions; =&gt; The NHA report 2021 for the year 2019 was finalized including information on immunization expenditure and during the discussions and consultations with Department of Finance and other relevant stakeholders, the implications of the data for policy decisions were discussed and the use of data for policy decisions were emphasized during the meetings and the NHA training workshops. The dissemination meeting of the NHA was postponed due to COVID-19 situation in Lao PDR. (supporting document: NHA final report in Eng and Lao)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ROII&apos; health metrics available - reduction in IM, U5, and cases/disease averted - attributable to immunization</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Return on Investment in Immunization (ROII) (NEW)- using OneHealth or similar tool, support MOH/MCHC to translate 2021-2025 investment in NIP into health impact and link to role of achieving SDGs">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">this activity should be re-discussed in view of Gavi transition discussions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Develop a framework for appropriate use of eIR to monitor EPI and the integrated EPI data in DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for the appropriate use of eIR including review of implementation of direct event capture and individual child tracker for improved service coverage and monitoring">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">After pilot testing and feasibility analysis of use of Direct Event Capture, it was decided that DEC is not used as it is not fully/practically used. Instead, iER is being used for tracking immunization as alternative.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for the appropriate use of eIR including review of implementation of direct event capture and individual child tracker for improved service coverage and monitoring">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">After pilot testing and feasibility analysis of use of Direct Event Capture, it was decided that DEC is not used as it is not fully/practically used. Instead, iER is being used for tracking immunization as alternative.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Launch and dissemination of the job aides/training tools and a full adoption of immunized child page in DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for information system integration with DHIS2 and for improvements in quality of data entry using the individual child tracker">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Direct Event Capture is completed for well child, nutrition and growth monitoring. However, iER has been developed for immunization tracking and currently used by EPI on Direct Event Capture.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA support for information system integration with DHIS2 and for improvements in quality of data entry using the individual child tracker">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Direct Event Capture is completed for well child, nutrition and growth monitoring. However, iER has been developed for immunization tracking and currently used by EPI on Direct Event Capture.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">9. Media is well informed on Immunization including activities update at central level (HR-40)
10.&#xA0;Communication Trarining for Health Workers, Village Health Volunteers and Mobilizers completed (HR-6, HR-28, HR-4, and HR-49)
11. Post training evaluation of all cadres completed
(HR-6, HR-28, HR-4, and HR-49)
&#xA0;12. Community level meetings, events and home visits in high risk areas are held (HR-45, HR-47 and HR-48)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to support the implementation of Communication for Immunization Strategic Plan and the implementation to GAVI HSS Objective 3 Communicaiton for development activities. It include: Targeted advocacy meetings, engagement and capacity development of National, Provincial, District Communication Management Committees and mass organizations to address ethnic and demand side barriers; system strengthening and capacity of health managers and providers build on C4D;Faciliated production/ reproduction of audio-video materials.">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. Two media briefings at the national level with the involvement of the UN and donor agencies have been held in March and June. One panel meeting COVID19 vaccination specific organized in June. 2. National level advocacy meeting conducted and subsequent Provincial advocacy meetings with mass organizations organized to address the importance of all type of immunization; Particular focus given to ethnic and demand-side barriers are discussed in each provinces selecting the high risk and low performing districts; Facilitators guide, sub-national training materials, agenda of the workshops are attached.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to support the implementation of Communication for Immunization Strategic Plan and the implementation to GAVI HSS Objective 3 Communicaiton for development activities. It include: Targeted advocacy meetings, engagement and capacity development of National, Provincial, District Communication Management Committees and mass organizations to address ethnic and demand side barriers; system strengthening and capacity of health managers and providers build on C4D;Faciliated production/ reproduction of audio-video materials.">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. Two media briefings at the national level with the involvement of the UN and donor agencies have been held in March and June. One panel meeting COVID19 vaccination specific organized in June. 2. National level advocacy meeting conducted and subsequent Provincial advocacy meetings with mass organizations organized to address the importance of all type of immunization; Particular focus given to ethnic and demand-side barriers are discussed in each provinces selecting the high risk and low performing districts; Facilitators guide, sub-national training materials, agenda of the workshops are attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Advocacy workshops are organized in 20 districts are village chiefs are sensitized on local government support for timely immunization and poor performing villages are mapped.
2. Community orientation in selected districts and villages on Fully Immunized Village model completed and started its implementation.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Effective advocacy and communication to promote increased coverage of children with zero dose and increase demand for vaccination, especially with focus on low performing and high risk districts:
1. Organize advocacy workshops at district level to ensure coordinated approach and priorities in high-districts (50) and in selected low performing villages (with village chiefs) (HR2-32, HR2-33, and HR34);
2. Provide technical assistance to Communication Task Force strengthening at national, provincial and district level (consisting of MoH, Local Council, Lao Front, Lao Women Union, Lao Youth, MoE, MoICT, Development Partners);
3. Provide technical assistance to strengthen the social mobilization network at district and community level to implement demand generation activities by mapping poor performing villages in terms of SBCC;
4. Organize community orientation meetings/training for community influencers, including village heads, religious leaders, etc with a focus on 50 high-risk districts based on the fully immunization village model concept">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Due to main focus on COVID19 communication, community mobilization, the activities and milestones will be implemented in 2022. The activities are linked to GAVI HSS 3 activities implementation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Planning for advocacy workshop for 50 high risk districts and design of mapping.
2. Communication Task Force meeting at National and Province level conducted and the report submitted to CCEH and discussed at monthly EPI meeting before June, 2021</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Effective advocacy and communication to promote increased coverage of children with zero dose and increase demand for vaccination, especially with focus on low performing and high risk districts:
1. Organize advocacy workshops at district level to ensure coordinated approach and priorities in high-districts (50) and in selected low performing villages (with village chiefs) (HR2-32, HR2-33, and HR34);
2. Provide technical assistance to Communication Task Force strengthening at national, provincial and district level (consisting of MoH, Local Council, Lao Front, Lao Women Union, Lao Youth, MoE, MoICT, Development Partners);
3. Provide technical assistance to strengthen the social mobilization network at district and community level to implement demand generation activities by mapping poor performing villages in terms of SBCC;
4. Organize community orientation meetings/training for community influencers, including village heads, religious leaders, etc with a focus on 50 high-risk districts based on the fully immunization village model concept">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">The recommendations from the evaluation of MNCH Strategic Planning Framework suggested that community mobilization and communication are essential to raise awareness about RMNCAH and motivate health seeking behavior. The Communication for Health Strategy has been in place in which the Center for Communication, Education and Health (CCEH) leads the implementation of the strategy. However, communications for the integrated services on RMNCAH has not been done adequately. Coordination and the involvement of various sectors in communication area is still limited, including lack of coordinating mechanism between the health sector and the non-health sector such as mass organizations that have well-established networks and relationships with communities. Such limitations lead to information about health failing to reach the whole population and difficulty in community mobilization. Therefore, to address this need Communication Taskforce on RMNCAH has been established with a set of roles and responsibilities of members from the health sector and the non-health sectors to work together and contribute towards achieving the goals of RMNCAH in Lao PDR. Though due to COVID19 pandemic and lockdown the main activities of Communication Task Force were focused on Covid19 vaccine introduction, a momentum during World Immunization Week has been build to revive advocacy on routine vaccines.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete end-of-ISDS transition activity review to report on the sustainability of ISDS activities in the 5 implementation provinces implementation in 5 regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="STOP Immunisation and Surveillance Data Specialist (ISDS) pilot transition, to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use, through sustained supportive supervision">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Scaling up of data strengthening activity using ISDS strategy is underway in two provinces (Savannakhet and Bolikhamxai). In Bolikhamxai it is already started but in Savannakhet it is delayed due to some challenges. To build the capacity of the new selected province staff, different activities were planned. One of these activities was experience-sharing visit. The new province staff travel to old ISDS provinces and visit selected district and HF to gain more experience on ISDS strategy and implementation of ISDS activities. Of the planned two experience sharing visits, the first one was conducted in Vientiane Capital on April 09, 2021. A team of four people from Bolikhamxay province travel to Vientiane capital and visited Sangthong district office and Nachaleun HC.
Support on EPI and surveillance data management through on the job training started in Bolikhamxi.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training conducted on DHIS2 data quality and analysis module to all province EPI manager and statistician/DHIS2 officers</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HMIS (cont&apos;d)- Intensify the efforts to improve the quality and use of data in DHIS2 through additional training on DHIS2 to all provincial EPI managers,surveillance officers,and statistician/DHIS2 officers.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Scaling up of data strengthening activity using ISDS strategy was planned in two provinces (Savannakhet and Bolikhamxai). Before ground support started, three days training was provided on EPI &amp; surveillance data management, and mentoring/coaching skill to coordinators and implementers of the activity. A total of 23 participants from five provinces (Houaphan, Phongsali, Xainyabouli, Savannakhet and Bolikhamxai) participated in the training. The training targeted DHP head, EPI managers, surveillance officers and statistician from each of the five provinces.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HMIS (cont&apos;d)- Intensify the efforts to improve the quality and use of data in DHIS2 through additional training on DHIS2 to all provincial EPI managers,surveillance officers,and statistician/DHIS2 officers.">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Scaling up of data strengthening activity using ISDS strategy was planned in two provinces (Savannakhet and Bolikhamxai). Before ground support started, three days training was provided on EPI &amp; surveillance data management, and mentoring/coaching skill to coordinators and implementers of the activity. A total of 23 participants from five provinces (Houaphan, Phongsali, Xainyabouli, Savannakhet and Bolikhamxai) participated in the training. The training targeted DHP head, EPI managers, surveillance officers and statistician from each of the five provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI committee has met at least once and minutes are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Vaccine safety and security(cont&apos;d)- (1) strengthening AEFI surveillance and management at all levels; (2) development of AEFI workplan and convening of AEFI committee">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">in 2021, the AEFI committee has been very active meeting in Feb and May to review serious AEFI investigation and conduct causality assessments. 
The committee has reviewed and provided input on the national AEFI guideline, adding AEFI management to the guideline and an example of how to fill in the reporting form. WHO is providing technical support to expand capacity at the subnational level to complete thorough investigations and causality assessments. 
Other updates: 
?	AEFI committee meeting concluded that the AEFI death case in Setthathirath was a coincidental event and was no associated with vaccines. The case died of congenital heart disease.
?	The AEFI after JE case 2 dropped the lawsuit in 2020. 
?	For Khounkham cases, the meeting suggested an MRI imaging for Khounkham to get a precise diagnosis.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Vaccine safety and security(cont&apos;d)- (1) strengthening AEFI surveillance and management at all levels; (2) development of AEFI workplan and convening of AEFI committee">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">in 2021, the AEFI committee has been very active meeting in Feb and May to review serious AEFI investigation and conduct causality assessments. 
The committee has reviewed and provided input on the national AEFI guideline, adding AEFI management to the guideline and an example of how to fill in the reporting form. WHO is providing technical support to expand capacity at the subnational level to complete thorough investigations and causality assessments. 
Other updates: 
?	AEFI committee meeting concluded that the AEFI death case in Setthathirath was a coincidental event and was no associated with vaccines. The case died of congenital heart disease.
?	The AEFI after JE case 2 dropped the lawsuit in 2020. 
?	For Khounkham cases, the meeting suggested an MRI imaging for Khounkham to get a precise diagnosis.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Updated district level live birth and under 1 estimates are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="DATA QUALITY II (NEW): Support development of agreed live birth and under 1 estimates for 148 districts using result of Lao Statistics Bureau (LSB) agricultural household survey and mid census data.">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">working to identify appropriate TA who can conduct required work at a distance given current COVID travel constraints</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strengthen programmatic sustainability through initiating PPP in the area of Immunizaiton</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to PHC and CHSS as part of the implementation of the Gavi assisted Health System Strengthening programme:
1) Support implementation of VHV mapping exercise, provide technical supervision to incorporate LQAS into DHIS2;
2) Contribute to start Public Private Partnership Initiative to support Laos Immunization Platform;
3) Provide overall guidance and TA support to MOH partners on the Gavi-assisted HSS programme monitoring;
4) Support robust forecasting by triangulation between coverage, utilization and stock level to ensure country vaccine procurement and forecasting, co-financing;
5) To initiate the assessment process on Effective Vaccine Management 2 and assist in EVM improvement plan">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. To strengthen Cold Chain System, a private-public partnership is established for one year to build the capacity of NIP. 
2. Village Health Volunteers in Lao PDR interface between the health system and the community and provides the first line of advice and health care to communities and play a central role in the CHSS of the overall PHC strategy. Information on key frontline workers is sketchy and unactionable. VHVs have been recruited by various vertical and development partner-supported projects and have received differential training, supplies, and incentives. There is no national geo-referenced master VHV list ? a complete database with basic information for all VHVs. This information deficit constrains effective planning, management, monitoring, evaluation of VHV work. UNICEF Lao PDR provided technical assistance to a Health Facility and VHV mapping and capacity assessment in one province in Lao PDR to address these crucial gaps in health system information. The mapping exercise was conducted in Bokeo province. The results have been widely shared with the government stakeholders and partners. The VHV/HF mapping will now be expanded to 10 more provinces. 3. Lot Quality Assurance Sampling Survey was carried out in 4 targeted districts (Sanamxay, Xepone, Pha Oudoum, and Bolikhan) in the Attapeua, Savannakhet, Bokeo, and Bolikhamsay provinces in February 2021. The survey conducted by MoH, UNICEF, the Laos Tropical and Public Health Institute (LTPHI), and the Liverpool School of Tropical Medicine (LSTM). It aimed to measure the performance of selected Reproductive, Maternal, Newborn, Child, and Adolescent Health (RMNCAH)and nutrition indicators. A follow-up survey is anticipated in one year to assess the extent to which the program is achieving the expected outcomes on DHSS and the key RMNCAH and nutrition indicators. The survey focused on service delivery to the client populations whose knowledge, practices, and health care service accessibility were measured.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Co-financing paid timely by the Government; Correct vaccine forecasting and procurment of vaccine is in plance to keep an optimum level of vaccine stock level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to PHC and CHSS as part of the implementation of the Gavi assisted Health System Strengthening programme:
1) Support implementation of VHV mapping exercise, provide technical supervision to incorporate LQAS into DHIS2;
2) Contribute to start Public Private Partnership Initiative to support Laos Immunization Platform;
3) Provide overall guidance and TA support to MOH partners on the Gavi-assisted HSS programme monitoring;
4) Support robust forecasting by triangulation between coverage, utilization and stock level to ensure country vaccine procurement and forecasting, co-financing;
5) To initiate the assessment process on Effective Vaccine Management 2 and assist in EVM improvement plan">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">The Lao government has been sensitized on co-financing commitment and advocacy session have held at higher level on on a trajectory towards financial sustainability. Since the next year will be the last year prior to phasing out of our support and fully self-financing of all vaccines, the government put the immunization as the key strategic program. The Lao PDR is in the process to full cover the left over of co-financing amount before year end. Involving private sector in fund mobilization for COVID19 vaccine, one important involvement the intermediate milestone is also achieved to building private public partnership and involve their contributions of vaccine financing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Sub-national level advocacy with district governors on immunization support conducted;
3.Coordination among different sectors at sub-national level on social mobilization is functional for Immuniz.demand generation
4. Promotional videos and radio spots aired and materials and media kits for media workshops and media breifing on new vaccines fully in use.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to support the implementation of Communication for Immunization Strategic Plan and the implementation to GAVI HSS Objective 3, HTU 32-33 Communicaiton for development activities; Support Lao PDR in planning, coordination and implementation of vaccine and address vaccine hesitancy:
1. Organize advocacy events/meetings for immunization at different levels, including advocacy with district governors to leverage the subnational support
2. Boost coordination at national level for harmonized social mobilisation work at all level in order to promote demand generation for immunization;
3. Technical assistance and guidance on Media engagement -- including media briefings, field visits to avoid missinformation
4. Provide technical support to MoH to produce and pre-test communication materials for advocacy and community engagement on immunization (including training), such as TV and radio spots, social media content, flyers, flip charts, etc">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">The main focus of the government and stakeholders were to support COVID19 vaccination communication. COVAX vaccination communication campaigns also highlighted the routine vaccination. UNICEF in collaboration with CCEH and WHO launched #VaccinateLaos campaign to mark COVID-19 vaccination rollout. Panel discussion organized for media representatives to ensure reporting of the correct and authentic information for communities across Lao PDR. As a part of #VaccinateLaos campaign, communication materials like informative posters, banners, more than 2500 copies of poster, 1 million stickers, 3500 t-shirts have been printed and used for campaign across the country. UNICEF produced 5 videos to focus on promoting COVID-19 vaccination, building trust in safety and effectiveness of vaccines. One of the videos featured the Minister of Health, Lao PDR. The total reach of the videos so far is 71,656 making 84,870 impressions. UNICEF has collaborated with Ms. Aluna THAVONSOUK, a Lao national singer, to produce a song to highlight safety and effectiveness of COVID-19 vaccines leading to the uptake of the vaccination in the country. UNICEF is strategizing community engagement (CE) activities with support from CCEH and its network. To facilitate interactive and participatory approach to communication, a flipchart to talk about COVID-19 and vaccination approach in Lao PDR has been developed . English and Lao versions of the flipchart is part of a toolkit that has been shared with a network of NGOs working on community engagement. To avoid duplication of communication efforts and align with all stakeholders, UNICEF has developed an online CE toolkit. UNICEF with CCEH engaged Lao Front for National Development (LFND) . orient the LFND provincial representatives about various COVID-19 communication tools . This resulted the representatives&apos; targeted approach to improving their community engagement activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.Preparatory work for sub-national level advocacy with district governors is done;
2.Coordination established between national and sub-national level on social mobilization scope of work for demand generation
3. Promotional videos and radio spots scripts finalized and materials and media kits for media workshops and media breifing on new vaccines developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to support the implementation of Communication for Immunization Strategic Plan and the implementation to GAVI HSS Objective 3, HTU 32-33 Communicaiton for development activities; Support Lao PDR in planning, coordination and implementation of vaccine and address vaccine hesitancy:
1. Organize advocacy events/meetings for immunization at different levels, including advocacy with district governors to leverage the subnational support
2. Boost coordination at national level for harmonized social mobilisation work at all level in order to promote demand generation for immunization;
3. Technical assistance and guidance on Media engagement -- including media briefings, field visits to avoid missinformation
4. Provide technical support to MoH to produce and pre-test communication materials for advocacy and community engagement on immunization (including training), such as TV and radio spots, social media content, flyers, flip charts, etc">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">The report also provided in other milestone</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Four cold rooms are functional 2. Procured Five Hundred temperature monitoring (fridge tag-2)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to implement GAVI HSS 3 and Top up #2 activities: Objective 4,HTU-4(HSS)-Cold chain Tool kits for all 20 technicians; Objective 4,HR 54 (HSS) Procurement of temperature monitoring (fridge tag-2);Objective 4,HR-55(HSS) Procure 4 cold chain maintenance trucks (4X4).Objective 4,HR- 58 (HSS)Procurement of transport 4refridgerated mini vans; Objective 4,HTU-2(HSS)Procurement of 4 Cold rooms">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">A private company namely Lao Industrial Solution has been recruited by UNICEF, which is the local agent of Haier Company in Laos, to install cold rooms. Team of MoH, UNICEF, and Lao conducted a pre-inspection visit in February and report prepared on the basis of which all shortcomings in newly renovated cold chain hubs have been eliminated. A total of 5 cold rooms, each 10m3 have been successfully installed in 4 geographical areas namely Luang Prabang, Vientiane Capital, Savannakhet, and Saravan provinces. Fridge tags are procured.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to implement GAVI HSS 3 and Top up #2 activities: Objective 4,HTU-4(HSS)-Cold chain Tool kits for all 20 technicians; Objective 4,HR 54 (HSS) Procurement of temperature monitoring (fridge tag-2);Objective 4,HR-55(HSS) Procure 4 cold chain maintenance trucks (4X4).Objective 4,HR- 58 (HSS)Procurement of transport 4refridgerated mini vans; Objective 4,HTU-2(HSS)Procurement of 4 Cold rooms">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">A private company namely Lao Industrial Solution has been recruited by UNICEF, which is the local agent of Haier Company in Laos, to install cold rooms. Team of MoH, UNICEF, and Lao conducted a pre-inspection visit in February and report prepared on the basis of which all shortcomings in newly renovated cold chain hubs have been eliminated. A total of 5 cold rooms, each 10m3 have been successfully installed in 4 geographical areas namely Luang Prabang, Vientiane Capital, Savannakhet, and Saravan provinces. Fridge tags are procured.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Six cold chain maintenance hubs establishment completed; 2. Quality assurance Introduced(SOPs)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to implement GAVI HSS 3 and Top up #2 activities: Objective 4;HTU-3 (HSS)-Establish 6 cold chain hubs(Layout approval,BOQ finalization,renovation,re-furbishment)">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Six cold chain hubs construction completed and report released; It is ready to accommodate cold rooms and function as a hub for vaccine logistics, cold chain repair hub, and place for capacity building of cold chain technicians from attached provinces.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to implement GAVI HSS 3 and Top up #2 activities: Objective 4;HTU-3 (HSS)-Establish 6 cold chain hubs(Layout approval,BOQ finalization,renovation,re-furbishment)">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Six cold chain hubs construction completed and report released; It is ready to accommodate cold rooms and function as a hub for vaccine logistics, cold chain repair hub, and place for capacity building of cold chain technicians from attached provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) 400 CCE installed; 
2) 567 CCE installation started</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CCEOP-Cold chain equipment installation-967 CCE(Subject to the De-linking aproval),">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">The report is reflected in other milestone</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CCEOP-Cold chain equipment installation-967 CCE(Subject to the De-linking aproval),">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">The report is reflected in other milestone</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Centre of excellence and QA following SOP&apos;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishment of Centre of Excellence and Quality assurance for Effective vaccine management and Cold chain system">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This milestone is re-programmed for 2022 and will be reflected as a part of EVM Improvement Plan. Development of SOP for Center of Excellence is planned after full implementation of Operational Deployment plan and completion of CCEOP.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishment of Centre of Excellence and Quality assurance for Effective vaccine management and Cold chain system">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This milestone is re-programmed for 2022 and will be reflected as a part of EVM Improvement Plan. Development of SOP for Center of Excellence is planned after full implementation of Operational Deployment plan and completion of CCEOP.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Center of Excellence established and core team of 15 &#xA0;is trained on key competencies at national level; team consist of 3 people in each 18 provinces are trained in Immunization Supply Chain and Logistics (total of 70 staff)
2. Mentoring program established&#xA0;for supporting cascade training and coaching and supervision activities;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop Human Resources for an efficient and sustainable&#xA0; immunization Supply Chain &amp; Logistics:&#xA0; 1.Build a pool of national and provincial trainers with enhanced training skills to impart effective competency-based training to lower levels; 2.Empower vaccine and cold chain manager at central, province and district level in skills in quality monitoring and supportive supervision to implement evidence-based coaching and supportive supervision across the lower levels; 3. Implement a comprehensive sustainable capacity building system composed of on-the-job trainings, coaching, supervision and monitoring for district and front-line health workers. (The activity is linked to Lao-German technical college with the team will build an alliance for incremental capacity building)">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Three national staff to support NIP and Central Store have been recruited. One Cold Chain Logistics, one Cold Chain Engineer, and one Cold Chain technician. The establishment of the Center of Excellence has been postponed till the completion of the CCEOP and Operational Deployment Plan. To get more detailed info on the needs of the Center of Excellence, the EVM2 assessment planned for 2022. To build a pool of national and provincial trainers to enhance skills, coaching and supervision a private company have been recruited which are currently engaged with NIP and regional team.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop Human Resources for an efficient and sustainable&#xA0; immunization Supply Chain &amp; Logistics:&#xA0; 1.Build a pool of national and provincial trainers with enhanced training skills to impart effective competency-based training to lower levels; 2.Empower vaccine and cold chain manager at central, province and district level in skills in quality monitoring and supportive supervision to implement evidence-based coaching and supportive supervision across the lower levels; 3. Implement a comprehensive sustainable capacity building system composed of on-the-job trainings, coaching, supervision and monitoring for district and front-line health workers. (The activity is linked to Lao-German technical college with the team will build an alliance for incremental capacity building)">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Three national staff to support NIP and Central Store have been recruited. One Cold Chain Logistics, one Cold Chain Engineer, and one Cold Chain technician. The establishment of the Center of Excellence has been postponed till the completion of the CCEOP and Operational Deployment Plan. To get more detailed info on the needs of the Center of Excellence, the EVM2 assessment planned for 2022. To build a pool of national and provincial trainers to enhance skills, coaching and supervision a private company have been recruited which are currently engaged with NIP and regional team.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Dose 2 of multi-age cohort vaccination scheduled for Q2 of 2020; tentative report on dose 2 implementation. Conduct PIE in conjunction with Dose 2 delivery.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to MOH and WHO-CO in planning nationwide HPV vaccine introduction. Support WHO with planning and leading in-country stakeholder meetings on micro-planning and communication, based on lessons learned from surrounding country demonstration projects, other national introductions and lessons from Lao PDR demonstration project. Plan for evaluation of national HPV vaccine introduction.">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been complete since April 2021. CDC provided TA for planning and national introduction. The second year vaccination took place from March-May 2021 with the PIE conducted in 3 provinces in March 29-April 9, 2021. CDC provided remote support for PIE planning.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Completion of Dose 2 of first cohort (multi-age cohort) and Dose 1 of second cohort (routine)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to MOH, WHO-CO, and UNICEF-CO with nationwide HPV vaccine introduction.Support WHO with planning and leading in-country stakeholder meetings, readiness assessment pre-launch, and monitor vaccine introduction. Plan for post-introduction evaluation of national HPV vaccine introduction following first cohort dose 2.">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been complete since April 2021. CDC provided TA for planning and national introduction. The second year vaccination took place from March-May 2021 with the PIE conducted in 3 provinces in March 29-April 9, 2021. CDC provided remote support for PIE planning.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to MOH, WHO-CO, and UNICEF-CO with nationwide HPV vaccine introduction.Support WHO with planning and leading in-country stakeholder meetings, readiness assessment pre-launch, and monitor vaccine introduction. Plan for post-introduction evaluation of national HPV vaccine introduction following first cohort dose 2.">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been complete since April 2021. CDC provided TA for planning and national introduction. The second year vaccination took place from March-May 2021 with the PIE conducted in 3 provinces in March 29-April 9, 2021. CDC provided remote support for PIE planning.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.EVM assessment conducted in the country. 2.Scale up of SOP for Preventive Maintenance of cold chain equipment at Health Facilities completed.3.Training of District level EPI health staff on SOP of vaccine forcasting /distribution completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to adapt SOPs to country context as per EVM improvement plan: policies and procedures, training on cold chain maintenance, vaccine management; provision of equipment and infrastructure, distribution, logistics information management system.">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">EVM assessment planned for 2022 and included in the plan. SOPs on cold chain equipment basic and preventive maintenance will follow in 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to adapt SOPs to country context as per EVM improvement plan: policies and procedures, training on cold chain maintenance, vaccine management; provision of equipment and infrastructure, distribution, logistics information management system.">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This is ongoing process supported by all stakeholders. There is a minor delay in production of SOPs.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to adapt SOPs to country context as per EVM improvement plan: policies and procedures, training on cold chain maintenance, vaccine management; provision of equipment and infrastructure, distribution, logistics information management system.">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This is ongoing process supported by all stakeholders. There is a minor delay in production of SOPs.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete end-of-ISDS transition activity review to report on the sustainability of ISDS activities in the 5 implementation provinces implementation in 5 regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="STOP Immunisation and Surveillance Data Specialist (ISDS) pilot transition, to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use, through sustained supportive supervision">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This milestone was transferred to WHO in Feb 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="STOP Immunisation and Surveillance Data Specialist (ISDS) pilot transition, to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use, through sustained supportive supervision">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This milestone was transferred to WHO in Feb 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) 50% of identified low-performing HCs have received supportive supervision and VHV capacity building training has taken place;(2) Service delivery job aides are rolled out to all provinces</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Quarterly Community Meetings (QCM) (cont&apos;d) are conducted in 7 provinces to strengthen microplanning, supportive supervision and role of community leaders, village health volunteers (VHV),etc. QCM is leveraged to ID &apos;low dose villages&apos; and low-performing health centers (defined as &lt;2 outreach per year)">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This work has been paused during lockdown related to COVID outbreak in Q2</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Quarterly Community Meetings (QCM) (cont&apos;d) are conducted in 7 provinces to strengthen microplanning, supportive supervision and role of community leaders, village health volunteers (VHV),etc. QCM is leveraged to ID &apos;low dose villages&apos; and low-performing health centers (defined as &lt;2 outreach per year)">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">This work has been paused during lockdown related to COVID outbreak in Q2</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Quarterly Community Meetings (QCM) (cont&apos;d) are conducted in 7 provinces to strengthen microplanning, supportive supervision and role of community leaders, village health volunteers (VHV),etc. QCM is leveraged to ID &apos;low dose villages&apos; and low-performing health centers (defined as &lt;2 outreach per year)">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">this does not appear in 2021 TCA TA workplan -- is this carried over from 2020?</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Protocol for R-RCM is developed reflecting the Lao context; (2) HPV PIE report is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support/NVI (link to HR2-19, HR2-25, HR2-26): (1) conduct routine rapid convenience monitoring (R-RCM) to idenifty and reach zero dose children; (2) Technical assistance in the planning, implementation, and evaluation of PIRI and/or SIA; (3) continue monitoring completion of HPV vaccine introduction">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">(1) Protocol of R-RCM https://drive.google.com/file/d/1gk26qA6-0jS2ZEB9gG1aHFR9Vy5pQJ_t/view on page 49 and 50
 (2) HPV PIE report ? One of the eight PIE components is still awaiting response, planned to be completed in Q3. Kobo was used to analyze the PIE data</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Application for support for the 2022 MR-SIA is prepared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support/NVI (link to HR2-19, HR2-25, HR2-26): (1) conduct routine rapid convenience monitoring (R-RCM) to idenifty and reach zero dose children; (2) Technical assistance in the planning, implementation, and evaluation of PIRI and/or SIA; (3) continue monitoring completion of HPV vaccine introduction">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">1. Technical and financial support provided in Q4 to conduct PIRI. Developed methodology to ID 50 priority districts based on Jan-Jun 2021 data factoring in ZD and undervaccinated children
2. Zero dose strategy drafted leveraging existing microplanning and QCM , which enable identification of zero dose children. Greater support for the existing components is required: microplan training, distribution of microplan guidelines, QCM and supportive supervision. Existing HSS grant should enable this 
3. HPV PIE completed and recommendations for improving delivery of HPV vaccination (including integration with other services) shared and agreed with MOH</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Training materials are prepared based on the finalised national AEFI guidelines and tested in the field; (2) Annual AEFI review meeting is held and its minute is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Vaccine safety and security (link to HR2-4, HR2-5): (1) strengthening AEFI surveillance and management at all levels; (2) development of AEFI workplan and convening of AEFI committee">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Vaccine safety and security: (1) national AEFI committee meeting was held on 05 and 10 of August 2021; An AEFI secretariate and technical meeting was held regularly, once every month and once a week, respectively. (2) National AEFI surveillance and management guidelines ? The National AEFI surveillance and management guidelines were drafted are being reviewed by NIP AEFI technical team. A consultation meeting is planned for December 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) At least 1 National AEFI Committee meeting held and its minute is available; (2) National AEFI surveillance and management guidelines finalised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Vaccine safety and security (link to HR2-4, HR2-5): (1) strengthening AEFI surveillance and management at all levels; (2) development of AEFI workplan and convening of AEFI committee">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">in 2021, the AEFI committee has been very active meeting in Feb and May to review serious AEFI investigation and conduct causality assessments. 
The committee has reviewed and provided input on the national AEFI guideline, adding AEFI management to the guideline and an example of how to fill in the reporting form. WHO is providing technical support to expand capacity at the subnational level to complete thorough investigations and causality assessments.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) AEFI data integrated in the DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HMIS (link to HSS activity HR-63,HR-3 to 7, HR-11 and HR-12) - Intensify the efforts to improve the quality and expanded use of data in DHIS2 down to health center level">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">?	Aggregate AEFI data is now included in the data collection form. The new data also integrated in to DHIS2 system. Starting January 2021, HFs are entering this data in the system.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Detail EIR implementation plan prepared and the EIR system development (ie tailored design, etc) finalized;

(2) Training material for EPI data management finalized;
(3) Develop detail plan and methodology for use of geospatial technology, and get secondary data from</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="DATA QUALITY (link to HSS activities HR2-1, HR2-2. HR2-3, HR2-8, HR2-9, HR2-10): (1) Support revision of training materials and rollout EPI data managment training; (2) subnational data quality strengthening in # priority provinces; (3) Conduct data quality assessment (DQA) in # provinces per year; (4) support use of geospatial technologies for better planning of immunization activities to identify missed communities and zero dose children (5) Support development and implementation of EIR">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Detail implementation plan and budget prepared for EIR rollout, please find attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Interactive dashboard developed for EPI; (2) SIA data integrated in the DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HMIS (link to HSS activity HR-63,HR-3 to 7, HR-11 and HR-12) - Intensify the efforts to improve the quality and expanded use of data in DHIS2 down to health center level">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">o	AEFI module integrated in to DHIS2 system (Both COVID and Routine Immunization). First round testing of the system conducted. The system will be ready for use mid of Nov 2021.
- For the dashboard minor delay but for the SIA major delay. In the current upgraded version of DHIS2 there is new function called add filter and this can be used to make the dashboard interactive. Even we can use this function, filter province or district or HFs and, and can see their performance. But we had a plan also to update the content of the dashboard by including vaccine stock indicators using the data from the new HF vaccine stock monitoring module. We can include these indictors and update the dashboard before the end of this year.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Pilot EIR in few districts (3 districts)
(2) Data quality assessment conducted in two province
(3) Primary geospatial data will be availabe from HFs and villages.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="DATA QUALITY (link to HSS activities HR2-1, HR2-2. HR2-3, HR2-8, HR2-9, HR2-10): (1) Support revision of training materials and rollout EPI data managment training; (2) subnational data quality strengthening in # priority provinces; (3) Conduct data quality assessment (DQA) in # provinces per year; (4) support use of geospatial technologies for better planning of immunization activities to identify missed communities and zero dose children (5) Support development and implementation of EIR">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">o	Data Quality assessment: - Data quality assessment was conducted in two provinces, four districts and seven HFs. Feedback and on-the-job training provided based on the findings.
o	Electronics Immunization Registry:- Detail implementation plan and budget prepared 
o	Geospatial Technology 
?	Detail implementation plan and budget prepared 
?	Existing data (secondary data) was compiled from different sources and cleaned for one province. The same activity continued for the remaining provinces. 
o	Regular performance feedback: Regularly (monthly) performance feedback of routine immunization prepared and shared with the users.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete routine supportive supervision of ongoing STOP ISDS transisition activities and continue summative assessment of STOP ISDS pilot implementation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="STOP Immunisation and Surveillance Data Specialist (ISDS) pilot transition, to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use, through sustained supportive supervision">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ToRs and individual workplans developed for key staff members</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Define roles and responsibilities of NIP staff members">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">?	MCHC organigram has been finalized and mapped against core competencies and ToRs to highlight gaps, this is to inform support to NIP to define future EPI decision-making mechanisms. 
?	To present recommendations from the organogram mapping exercise to the NIP/MCHC by end of year. 
?	A workplan will be developed for 2022 skills transfer activities for 3-5 NIP individuals.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Define roles and responsibilities of NIP staff members">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">MCHC organigram finalized, will be updated as required.
? Individual workplans for key staff members to be developed, linked to final 2021 AOP</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Define roles and responsibilities of NIP staff members">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">MCHC organigram finalized, will be updated as required.
? Individual workplans for key staff members to be developed, linked to final 2021 AOP</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Day to day support to strengthen capacity in specified areas and individuals</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">On-the-job capacity building for key NIP/MCHC staff has and will continue to be incorporated into support across the work and deliverables of the LMC grant.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">On-the-job capacity building for key NIP/MCHC staff has and will continue to be incorporated into support across the work and deliverables of the LMC grant.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual capacity building plans (inclusive of off the job and in-service training, and other coaching modalities)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Given delays and ongoing constraints around NIP time and capacity propose revised approach as indicated in reprioritization document (Annex 2 as attached above), to include:
o Map MCHC organogram against core competencies and ToRs to highlight gaps
o Working with NIP 3-5 individuals for on-the-job, intensive support</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Given delays and ongoing constraints around NIP time and capacity propose revised approach as indicated in reprioritization document (Annex 2 as attached above), to include:
o Map MCHC organogram against core competencies and ToRs to highlight gaps
o Working with NIP 3-5 individuals for on-the-job, intensive support</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual>
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training workshops</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Given delays and ongoing constraints around NIP time and capacity propose revised approach as indicated in reprioritization document (Annex 2 as attached above), to include:
o Map MCHC organogram against core competencies and ToRs to highlight gaps
o Working with NIP 3-5 individuals for on-the-job, intensive support</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Given delays and ongoing constraints around NIP time and capacity propose revised approach as indicated in reprioritization document (Annex 2 as attached above), to include:
o Map MCHC organogram against core competencies and ToRs to highlight gaps
o Working with NIP 3-5 individuals for on-the-job, intensive support</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual>
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Skills needs assessments</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Given delays and ongoing constraints around NIP time and capacity propose revised approach as indicated in reprioritization document (Annex 2), to include:
o Map MCHC organogram against core competencies and ToRs to highlight gaps
o Working with NIP 3-5 individuals for on-the-job, intensive support</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">Given delays and ongoing constraints around NIP time and capacity propose revised approach as indicated in reprioritization document (Annex 2), to include:
o Map MCHC organogram against core competencies and ToRs to highlight gaps
o Working with NIP 3-5 individuals for on-the-job, intensive support</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual>
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Revised ToRs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen functioning of the ICC and TWGs">
      <location ref="LA"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="LA"></location>
      <comment>
       <narrative xml:lang="EN">TORs for existing governance structures (RMNCAH sub-committees, ICC and TWGs) mapped and updated where required and will inform support to NIP to define future EPI decision-making mechanisms, related to sub-objective 1.3.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual capacity building plans (inclusive of off the job and in-service training, and other coaching modalities)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual>
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Skills needs assessments</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop and implement plans to address capacity gaps">
      <location ref="LA"></location>
     </target>
     <actual>
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="LA"></location>
     </target>
     <actual value="Completed">
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="LA"></location>
     </target>
     <actual>
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry digital package configured and installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="LA"></location>
     </target>
     <actual value="On Track">
      <location ref="LA"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="LA"></location>
     </target>
     <actual>
      <location ref="LA"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
